UVA1 phototherapy treatment morphea UV phototherapy
1. New technology high-power UV solid-state cold light source
2. Array type reflective light path design
3. Superconducting material to make the heat-conducting substrate
4. Irradiation intensity multi-grade adjustment function
5. Five built-in conventional treatment programs
6. Built-in precision sensor for real-time monitoring
Overview
Solid-state Cold Light Source New technology high-power UV solid-state cold light source, high output energy, long service life. |
Superconducting Substrate Superconducting material to make the heat- conducting substrate, with the heat dissipation system based on the aerodynamic principle to ensure the reliable and stable work of the light source. |
8" Touch Screen 8'' capacitive touch screen with a large color character display for clear and easy-to-understand operating instructions. |
Flexible The ergonomic lifting mechanism of is very flexible for the operation of the treatment head and can meet the clinical needs. |
Features
1. New technology high-power UV solid-state cold light source, high output energy, long service life.
2. Array type reflective light path design, the light source output is more uniform.
3. Superconducting material to make the heat-conducting substrate, with the heat dissipation system based on the aerodynamic principle to ensure the reliable and stable work of the light source.
4. The large treatment area of can meet more diversified clinical treatment needs.
5. Irradiation intensity multi-grade adjustment function, fully meet the individualized treatment of patients with different degrees of tolerance.
6. The ergonomic lifting mechanism of is very flexible for the operation of the treatment head and can meet the clinical needs.
7. The solid base and trolley of ensure the safety of the device's operation while enhancing its mobility and flexibility.
8. 8'' capacitive touch screen with a large color character display for clear and easy-to-understand operating instructions.
9. Five built-in conventional treatment programs to make the operation more convenient.
10. Irradiation intensity calibration function, used in conjunction with the dose mode, makes clinical treatment more accurate. (4002A1 is applicable)
11. Built-in precision sensor for real-time monitoring of light source usage, making equipment operation more stable and reliable.
Specification
Irradiation Area | 4002A1: 1600cm2±10% |
4002A2: 1024cm2±10% | |
Working Distance | 5cm±1cm |
Size | 650mm×1139.5mm×1124mm |
Working Voltage | AC 220V, 50Hz |
Irradiation Intensity | 4~50 mW/cm2 |
Irradiation Dose | ≤200J/cm2 |
What are the indications for UVA1?
UVA1 radiation can be used to treat the following skin diseases:
Atopic dermatitis
Scleroderma (various forms)
Cutaneous T-cell lymphoma
Urticaria pigmentosa
Extragenital lichen sclerosus
Granuloma annulare.
Types of Scleroderma
There are two major classifications of scleroderma: localized scleroderma and systemic sclerosis (SSc). Other forms or subclassifications, each with its own characteristics and prognosis, may be identified through future research.
Localized Scleroderma The changes, which occur in localized scleroderma, are usually found in only a few places on the skin or muscles, and rarely spread elsewhere. Generally, localized scleroderma is relatively mild. The internal organs are usually not affected, and persons with localized scleroderma rarely develop systemic scleroderma. Some laboratory abnormalities commonly seen in systemic scleroderma are frequently absent in the localized form.
Systemic scleroderma (systemic sclerosis) The changes occurring in systemic scleroderma may affect the connective tissue in many parts of the body. Systemic scleroderma can involve the skin, esophagus, gastrointestinal tract (stomach and bowels), lungs, kidneys, heart and other internal organs. It can also affect blood vessels, muscles and joints. The tissues of involved organs become hard and fibrous, causing them to function less efficiently.
The seriousness will depend on the parts of the body, which are affected, and the extent to which they are affected. A mild case can become more serious if not properly treated. Prompt and proper diagnosis and treatment by qualified physicians may minimize the symptoms of scleroderma and lessen the chance for irreversible damage.